GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery - Wikidata - wikimedia - TriplyDB

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

http://www.wikidata.org/entity/Q36942165

about

Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery β-cell function after weight-loss induced by bariatric surgery.Bariatric surgery and obesity: influence on the incretins Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.Effects of laparoscopic gastric plication (LGP) in patients with type 2 diabetes, one year follow-up.Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis.Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission.Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines.Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency.GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.What is the Mechanism Behind Weight Loss Maintenance with Gastric Bypass?A High-Throughput Automated Microfluidic Platform for Calcium Imaging of Taste Sensing.Diabetes after Bariatric Surgery.Spontaneous Hypoglycemia After Islet Transplantation: The Case For Using Non-Hepatic Sites.Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution?Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Endocrine Function after Bariatric Surgery.Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats.Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition.Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission.Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats.Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

P2860

Q26995145-753B06F1-1288-4049-93CD-9C9611E319A3 Q27027920-B1309BB7-67A6-41BB-9AE9-F7A00911351D Q28080484-9741B423-93A2-4BE4-B272-5A00CFC5CE67 Q28080912-19941867-88F7-4DF5-8724-1F921A227AC1 Q33569986-4DE66E7E-626B-4E10-957D-97F0FB2B8B96 Q33761529-2BA90E25-6071-4DCC-9A84-89ECD1327B74 Q33816658-B21ED3D6-3FF2-4C53-8384-52C4B92799CB Q33838154-4E993336-C662-4B50-AFED-E8296F27A9B4 Q34490397-960D7EB8-DAF9-44EC-8008-541927EB2999 Q35360690-8F59AB2C-5B99-4A4C-A357-9384D4A0A460 Q35704336-41BDF12A-4570-4E0B-8A29-2CF0F1E0D5DA Q35857481-41C8D79C-7A7F-44C8-8275-922C341BCC90 Q36978258-2206F981-C599-423C-9F3F-FDD7E2975AE2 Q37212797-FA968504-AADA-4817-B67A-562AA1FFC009 Q37660926-11B72DF0-E578-4096-AF92-15D1A3C085C6 Q37670181-DD3A59CE-2EA6-4EFC-BA5F-CFE71461715F Q38146960-B15D0107-4A6E-45E2-A1B6-7634DFD5DAA3 Q38270358-F5CBAEA7-CA77-4FF9-BF63-F7F0948F4856 Q38307449-FDE60E86-D17A-4575-BED2-8C85C430BD66 Q38514840-2C5BCBC5-8E7C-4EB6-9B1B-E4B0FE6F17C9 Q38655873-243056AE-DFA5-4B3B-BE1A-4BF09FF08009 Q38758861-C859C3CF-0FD3-49DF-9666-1A8C246E551A Q38812184-676705CB-2A64-4AB8-A820-2CB187272843 Q38950021-705E384B-8CE0-4C55-BBCF-7CEF2DA2788B Q38965089-16E08C82-AB84-45A8-B406-AB6D586D6482 Q39047697-EF647779-CF9B-495B-B082-EE50B14302A6 Q39390970-6BB564F7-AFBE-4635-A30C-C555A3A6E0E5 Q47416302-63865B8A-C595-4164-B0E4-9A4861B80DAE Q47607423-478DECD2-7130-4B12-962C-4DDCF9E9DDD0 Q48220785-9AAFA6E0-38DB-44DD-8E6D-C2C0CF2BF8E9 Q48231744-20D27130-7F3F-40D2-A203-186C9C6DCC6D Q50683780-3A775071-DA2F-4738-952D-FDCDAD9521E7 Q51245449-59FDD120-C59A-484E-9BC8-CD255EC536EE Q51297618-8155DE16-6CC0-4439-A39D-9870DE469DB0 Q58167278-013FC6C0-1C92-421B-AD80-8D6FC278C4A9 Q58447498-88E299F4-B2E7-49F5-BF5C-0BB8BA3B9660 Q58447614-BE8AF185-11A8-4A65-A97B-5102EA7540B4

P2860

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

http://www.wikidata.org/entity/Q36942165

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

GLP-1 action and glucose toler ...... s after gastric bypass surgery

@en

type

label

GLP-1 action and glucose toler ...... s after gastric bypass surgery

@en

prefLabel

GLP-1 action and glucose toler ...... s after gastric bypass surgery

@en

P1433

Q36942165-E489CD95-A0BD-456E-9334-E202BB8BAAB4

P1476

Q36942165-B53B1DBE-9B13-413B-8F80-83FF7D4EDE1F

P2093

Q36942165-3605E429-9340-4794-893C-3DC93827C5B8

Q36942165-4B750E02-9093-429D-AE5C-273CCFFC9253

Q36942165-7A2BA6BA-DC9D-42C9-B84E-75EC90D441E0

Q36942165-95B95FA6-DFB4-4CA1-AA33-E9A69EC4561A

Q36942165-E3ABDCD1-6034-403C-8D90-48BEF108EBA0

P2860

Q36942165-00EAFF50-095C-4FD8-8632-0DCF753815DE

Q36942165-1111506C-76E7-4C33-B150-D49BDEE292CB

Q36942165-11551B75-6D8F-4A81-9365-1E27E86ED18B

Q36942165-11AC5B3B-66F3-4E28-A796-AAE2C533ECBA

Q36942165-183C6838-5A8B-4ADA-B6A5-747D2EDCAFCD

Q36942165-20C8F171-489B-4541-B0CB-5D1B7AB0A325

Q36942165-21C955F7-EBBC-4F3C-BB45-09044280D8D3

Q36942165-2A80DDE6-F028-4CF0-B9B6-4DB4F2B2B0EF

Q36942165-399A4C6F-9812-4FA2-AA81-DE9F132CA049

Q36942165-41BCFA9A-D01A-42E8-BA04-2D86DE0F1B35

P304

Q36942165-545C89AE-3068-4529-9F1E-6F1CD3340D89

P31

Q36942165-DD29EFBD-09A0-4FCD-96F2-8287C478078A

P356

Q36942165-68B36C03-AF46-44F9-AE19-AD4DBC921A22

P407

Q36942165-51900587-503C-4D01-AAE2-CAF7F4BB65D1

P433

Q36942165-EC8275A9-505D-446E-9EAD-06D08E6A0953

P478

Q36942165-06A0EC0E-1AD3-4F9D-AE8B-5F3B61667695

P577

Q36942165-7EAD1449-5137-470F-A446-E3F9A1D52611

P5875

Q36942165-584527C6-3347-47C0-819D-44AAB41E3D4C

P698

Q36942165-8D686B93-684D-42D6-9810-AED3306E3999

P921

Q36942165-3F758FE3-BA50-4E88-9E87-B29AF2189B37

P932

Q36942165-3CFDADDD-506A-4DF0-BEAF-6726F4690AD0

P356

P1433

P1476

GLP-1 action and glucose toler ...... s after gastric bypass surgery

@en

P2093

Amanda Jiménez

http://www.w3.org/2001/XMLSchema#string

Antonio Lacy

http://www.w3.org/2001/XMLSchema#string

Josep Vidal

http://www.w3.org/2001/XMLSchema#string

Judith Viaplana-Masclans

http://www.w3.org/2001/XMLSchema#string

Roser Casamitjana

http://www.w3.org/2001/XMLSchema#string

P2860

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus.

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

Bariatric surgery versus intensive medical therapy in obese patients with diabetes.

Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.

The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.

Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion

P304

2062-2069

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-1535

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235380795

http://www.w3.org/2001/XMLSchema#string

P698

23359363

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3687297

http://www.w3.org/2001/XMLSchema#string